Enhanced Methods and Apparatuses for Reducing Bleeding via Coordinated Trigeminal and Vagal Nerve Stimulation
Legal Citation
Summary of the Inventive Concept
Improved systems and methods for reducing bleeding in patients by simultaneously stimulating the trigeminal and vagal nerves, incorporating real-time feedback mechanisms and advanced sensor technologies to enhance treatment efficacy and safety.
Background and Problem Solved
The original patent disclosed methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation. However, the existing patent had limitations in terms of adjusting stimulation intensity in real-time, remote monitoring, and power source lifespan. The new inventive concept addresses these limitations by introducing advanced sensor technologies, real-time feedback mechanisms, and miniaturized stimulators with extended power sources.
Detailed Description of the Inventive Concept
The enhanced system for reducing bleeding in patients comprises a neural stimulator configured to simultaneously stimulate the trigeminal and vagal nerves, and a sensor for detecting blood coagulation levels. The neural stimulator adjusts the stimulation intensity based on the detected blood coagulation levels, ensuring optimal treatment efficacy. Additionally, the system includes a wearable device and a mobile application for remotely monitoring and adjusting the stimulation intensity. The neural stimulation device features a miniaturized stimulator and an extended lifespan power source, enhancing user convenience and reducing maintenance requirements.
Novelty and Inventive Step
The new claims introduce the concept of real-time feedback mechanisms, advanced sensor technologies, and miniaturized stimulators with extended power sources, which are not present in the original patent. These advancements provide a significant improvement in treatment efficacy, safety, and user convenience, thereby constituting a novel and non-obvious inventive step.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include the use of different sensor technologies, such as optical or acoustic sensors, to detect blood coagulation levels. Additionally, the system could be adapted for use in various medical procedures, such as surgical interventions or trauma care, or integrated with other medical devices, such as patient monitoring systems.
Potential Commercial Applications and Market
The enhanced system for reducing bleeding in patients has significant commercial potential in the medical device industry, particularly in the areas of surgical interventions, trauma care, and patient monitoring. The target market includes hospitals, clinics, and medical research institutions, with potential for expansion into the consumer market for personal health monitoring and emergency response applications.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, specifically neural stimulation technologies for hemostasis and bleeding control, involving electrical nerve stimulation techniques and medical device design
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in neurostimulation, electrical medical devices, sensor integration, and physiological monitoring technologies, holding advanced degrees and practical experience in developing neural stimulation systems
Obviousness Rationale
A person having ordinary skill in the art would recognize that adding real-time feedback mechanisms, sensor technologies, and adaptive stimulation to the existing neural stimulation approach represents a predictable engineering solution for improving treatment precision and patient outcomes. The core concept of trigeminal and vagal nerve stimulation remains consistent, with the PTD introducing incremental technological enhancements that would be obvious to implement using standard medical device design principles. These variations represent logical extensions of the source patent's fundamental neural stimulation methodology.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,788 |
|---|---|
| Title | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
| Assignee(s) | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH |